ZAQS.ORG

Wednesday, June 17, 2026 3:10 PM ET

CNBC - Health

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

2 hours ago

Biotech IPO revival faces competition from cash-rich big pharma buyers

1 day ago

Centene to offer buyouts to some employees as health insurer cuts costs

1 day ago

Drugmakers race to find a place in the next wave of obesity drugs

4 days ago

CVS Health executives on reducing healthcare's biggest pain points

4 days ago

Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'

5 days ago

How screwworm in U.S. cattle herds could re-inflate record beef prices

6 days ago

The space race is coming for pharma: Why drug development is heading to orbit

7 days ago

Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion

8 days ago

Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why

9 days ago

GLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniors

9 days ago

Food supply 'not at risk' after new Texas screwworm cases, USDA secretary says

9 days ago

Weight loss drug maker sinks 23% after new safety data spooks investors

9 days ago

U.S. confirms second Texas screwworm case, Canada restricts livestock imports

11 days ago

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

11 days ago

Warren Buffett disciple Guy Spier's rare cancer changed how he values everything

11 days ago

An 'EpiPen' for heart attacks?: The market has yet to give this drug stock credit

12 days ago

As the World Cup kicks off, health officials are focused on more than Ebola

13 days ago

'Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-Covid

13 days ago

Eli Lilly's top dealmaker says don't be surprised to see more M&A

13 days ago

Biotech Abivax sinks 43% as cancer cases cloud trial data for bowel disease drug

8 days ago

Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trial

15 days ago

Why Trump reversed course to fast-track psychedelic drugs for mental healthcare

17 days ago

Replimune to resubmit twice rejected drug for approval after FDA shakeup

17 days ago

Oura is launching its smallest smart ring yet, shrinking wearable design by 40%

20 days ago

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

20 days ago

Amazon's top health exec is stepping down, will be replaced by Amwell co-founder

20 days ago

Trump officials hit California with Medicaid funding freeze

20 days ago

Healthy Returns: Eli Lilly makes a new push into vaccines — here's what to know

21 days ago

Signos grows foothold in weight-loss wave fueled by GLP-1s with AI tracking

21 days ago

How one medical supply CEO is navigating the oil price shock

21 days ago

Eli Lilly says next-generation weight loss drug clears crucial obesity trial

27 days ago